Experts react to Moderna's 94.5% effective vaccine against Covid-19

Moderna Inc said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S.

company in a week to report results that far exceed expectations. Following are reactions to the news. STEPHEN EVANS, PROFESSOR OF PHARMACOEPIDEMIOLOGY, LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE “This announcement from Moderna is a further encouragement that vaccines will be found to not only have an acceptable efficacy, but an efficacy that.

This article is no longer available in our repository.

There could be multiple reasons for this.